10-79942782-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_003019.5(SFTPD):c.297G>A(p.Lys99=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0186 in 1,612,094 control chromosomes in the GnomAD database, including 454 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.033 ( 136 hom., cov: 32)
Exomes 𝑓: 0.017 ( 318 hom. )
Consequence
SFTPD
NM_003019.5 synonymous
NM_003019.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.138
Genes affected
SFTPD (HGNC:10803): (surfactant protein D) The protein encoded by this gene is part of the innate immune response, protecting the lungs against inhaled microorganisms and chemicals. The encoded protein may also be involved in surfactant metabolism. [provided by RefSeq, Jul 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 10-79942782-C-T is Benign according to our data. Variant chr10-79942782-C-T is described in ClinVar as [Benign]. Clinvar id is 165217.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-79942782-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.138 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.074 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFTPD | NM_003019.5 | c.297G>A | p.Lys99= | synonymous_variant | 3/8 | ENST00000372292.8 | NP_003010.4 | |
SFTPD | XM_011540087.2 | c.297G>A | p.Lys99= | synonymous_variant | 3/8 | XP_011538389.1 | ||
SFTPD | XM_011540088.3 | c.297G>A | p.Lys99= | synonymous_variant | 3/7 | XP_011538390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFTPD | ENST00000372292.8 | c.297G>A | p.Lys99= | synonymous_variant | 3/8 | 1 | NM_003019.5 | ENSP00000361366 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0329 AC: 5006AN: 152140Hom.: 133 Cov.: 32
GnomAD3 genomes
AF:
AC:
5006
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0176 AC: 4436AN: 251436Hom.: 64 AF XY: 0.0171 AC XY: 2326AN XY: 135884
GnomAD3 exomes
AF:
AC:
4436
AN:
251436
Hom.:
AF XY:
AC XY:
2326
AN XY:
135884
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0171 AC: 25025AN: 1459836Hom.: 318 Cov.: 31 AF XY: 0.0169 AC XY: 12264AN XY: 726366
GnomAD4 exome
AF:
AC:
25025
AN:
1459836
Hom.:
Cov.:
31
AF XY:
AC XY:
12264
AN XY:
726366
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0330 AC: 5024AN: 152258Hom.: 136 Cov.: 32 AF XY: 0.0322 AC XY: 2399AN XY: 74446
GnomAD4 genome
AF:
AC:
5024
AN:
152258
Hom.:
Cov.:
32
AF XY:
AC XY:
2399
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
41
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Lys99Lys in exon 3 of SFTPD: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 7.5% (331/4406) of Af rican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs17885228). - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at